{"organizations": [], "uuid": "21130f17bebb6dd04e9c32ebf614f51787eb67f2", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180228.html", "section_title": "Archive News &amp; Video for Wednesday, 28 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-horizon-pharma-plc-announces-q4-no/brief-horizon-pharma-plc-announces-q4-non-gaap-earnings-per-share-0-29-idUSASB0C7YQ", "country": "US", "domain_rank": 408, "title": "BRIEF-Horizon Pharma PLC Announces Q4 Non-Gaap Earnings Per Share $0.29", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.013, "site_type": "news", "published": "2018-02-28T20:10:00.000+02:00", "replies_count": 0, "uuid": "21130f17bebb6dd04e9c32ebf614f51787eb67f2"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-horizon-pharma-plc-announces-q4-no/brief-horizon-pharma-plc-announces-q4-non-gaap-earnings-per-share-0-29-idUSASB0C7YQ", "ord_in_thread": 0, "title": "BRIEF-Horizon Pharma PLC Announces Q4 Non-Gaap Earnings Per Share $0.29", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "brief-horizon pharma plc", "sentiment": "negative"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 28 (Reuters) - Horizon Pharma Plc:\n* ANNOUNCES FOURTH-QUARTER AND FULL-YEAR 2017 RESULTS\n* Q4 NON-GAAP EARNINGS PER SHARE $0.29\n* SEES FY 2018 SALES $1.15 BILLION TO $1.18 BILLION * Q4 SALES $274.2 MILLION * Q4 GAAP LOSS PER SHARE $0.28 * ‍FULL-YEAR 2018 ADJUSTED EBITDA GUIDANCE OF $370 MILLION TO $395 MILLION​\n* Q4 EARNINGS PER SHARE VIEW $0.22, REVENUE VIEW $264.5 MILLION -- THOMSON REUTERS I/B/E/S\n* FY2018 REVENUE VIEW $1.14 BILLION -- THOMSON REUTERS I/B/E/S\n* HORIZON PHARMA SAYS Q4 NET SALES DRIVEN BY CONTINUED STRONG GROWTH FROM CO‘S ORPHAN & RHEUMATOLOGY BUSINESS UNITS​ Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-28T20:10:00.000+02:00", "crawled": "2018-03-01T21:00:16.000+02:00", "highlightTitle": ""}